Glucose metabolism in children with renal failure: oral or intravenous glucose tolerance

Summary:

There is debate about the most suitable test for investigation of glucose tolerance in children with chronic renal failure. We therefore studied the agreement between the two most commonly used glucose tolerance tests in 33 children with chronic renal failure (mean age 10.9 ± 5.3 years, median GFR was 24 ml/min/1.73 m²). All children underwent an oral glucose tolerance test (OGTT) with blood sampling up to 180 minutes and after an oral load of 1.75 g/kg and a standard intravenous glucose tolerance test (IVGTT) using 0.5 g/kg i.v. The two tests were performed at an interval of 23 ± 5 days, with 9 patients having the OGTT before and 24 after the IVGTT. In order to account for the differing glucose load, a subgroup of 19 patients also received a glucose infusion test (GIT) using a total of 1.75 g/kg i.v. On IVGTT, 27 patients had a normal and 6 had a pathological glucose decay constant (k-value). On OGTT, 12 patients had an impaired glucose tolerance (IGT) and 3 patients were diabetic according to WHO standard, and only 18 patients had a normal glucose tolerance. While there was good correlation between both glucose and insulin concentrations between IVGTT and OGTT, only when reapplying the WHO criteria of a glucose concentration below 6.7 mmol/l to the concentration measured 180 minutes instead of 120 minutes after oral glucose load, the agreement between the two tests improved. The proportion of normal findings on GIT when compared to OGTT was identical. When using the appropriate definitions for normal and abnormal carbohydrate tolerance, interestingly the insulin (IRI) concentrations on OGTT were not discriminative between the normal and the pathological group, whereas IRI first phase secretion on IVGTT and IRI 0-180 AUC on GIT did discriminate. We conclude that the standard WHO OGTT criteria may have to be reconsidered in children with chronic renal failure and that OGTT should be extended to 180 minutes. The IVGTT, particularly when insulin early phase secretion (at 0, 1, 3 and 5 minutes) is also monitored, provides a reliable test for assessing glucose tolerance in children with chronic renal failure.

Chronic renal failure - oral glucose tolerance test - intravenous glucose tolerance test - insulin secretion

References

• 1 Alford M J, Martin F I, Pearson M J. The significance and interpretation of mildly abnormal oral glucose tolerance.  Diabetologia. 7 173-180 1971; 
• 2 Balsam M J, Kaje R, Baker L. Chemical diabetes in children: glucose tolerance tests.  Metabolism. 22 283-288 1973; 
• 3 DeFronzo R A, Andres R, Edgar P, Walker W G. Carbohydrate metabolism in uremia: a review.  Medicine (Baltimore). 52 469-481 1973; 
• 4 Filler G, Amendt P, Kohnert K D, Devaux S, Ehrich J H. Glucose tolerance and insulin secretion in children before and during recombinant growth hormone treatment.  Horm Res. 50 32-37 1998; 
• 5 Filler G, Amendt P, von Bredow M A, Ehrich J H. Transient diabetes mellitus and peripheral insulin resistance following tacrolimus intoxication in a child after renal transplantation.  Nephrol Dial Transplant. 12 334-336 1997; 
• 6 Filler G, Amendt P, von Bredow M A, Rohde W, Ehrich J H. Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis.  Eur J Pediatr. 157 738-742 1998; 
• 7 Haffner D, Nissel R, Wuhl E, Schaefer F, Bettendorf M, Tonshoff B, Mehls O. Metabolic effects of long-term growth hormone treatment in prepubertal children with chronic renal failure and after kidney transplantation. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.  Pediatr Res. 43 209-215 1998; 
• 8 Hurter P, Gercken G, Ranke M, Bierich J R. [Studies on glucose tolerance and plasma lipids in children and young adults with potential diabetes]. [Article in German].  Monatsschr Kinderheilkd. 117 665-671 1969; 
• 9 Kahn C B, Soeldner J S, Gleason R E, Rojas L, Camerini-Davalos R A, Marble A. Clinical and chemical diabetes in offspring of diabetic couples.  Engl J Med. 281 343-347 1969; 
• 10 Lauritzen J B, Lauritsen K B, Olsen M E, Timmerman I. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.  Metabolism. 31 1096-1099 1982; 
• 11 Mak R H. Insulin, branched-chain amino acids, and growth failure in uremia.  Pediatr Nephrol. 12 637-642 1998; 
• 12 Mak R H. Insulin secretion and growth failure in uremia.  Pediatr Res. 38 379-383 1995; 
• 13 Marble A, Ferguson B D. Diagnosis and classification of diabetes mellitus and the nondiabetic melliturias. In: Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS (eds). Joslins diabetes mellitus, 12th edn Lea & Febinger, Philadelphia pp 332-352 1985
• 14 Olefsky J M, Farquhar J W, Reaven G M. Do the oral and intravenous glucose tolerance tests provide similar diagnostic information in patients with chemical diabetes mellitus?.  Diabetes. 22 202-209 1973; 
• 15 Porte D. Banting lecture 1990. Beta-cells in type II diabetes mellitus.  Diabetes. 40 166-180 1991; 
• 16 Rosenbloom A L. Criteria for interpretation of the oral glucose tolerance tests in children and insulin responses with normal and abnormal tolerance.  Metabolism. 22 301-395 1973; 
• 17 Schmitz O, Orskov L, Lund S, Moller N, Christiansen J S, Orskov H. Glucose metabolism in chronic renal failure with reference to GH treatment of uremic children.  J Pediatr Endocrinol. 6 53-59 1993; 
• 18 Schwartz G J, Brion L P, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.  Pediatr Clin North Am. 34 571-590 1987; 
• 19 Shasha S M, Nusem D, Kanter Y, Weiner F. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.  Isr J Med Sci. 24 15-19 1988; 
• 20 Srikanta S, Ganda O P, Gleason R E, Jackson R A, Soeldner J S, Eisenbarth G S. Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose.  Diabetes. 33 717-720 1984; 
• 21 Steinmuller T M, Graf K J, Schleicher J, Leder K, Bechstein W O, Mueller A R, Dette K, Schulz E, Neuhaus P. The effect of FK506 versus cyclosporine on glucose and lipid metabolism-a randomized trial.  Transplantation. 58 669-674 1994; 
• 22 Zuppinger K. Hypoglycemia in childhood. Evaluation of diagnostic procedures. [Monographs in Paediatrics 4] S. Karger, Basel P6-17 1975

1 CRF = chronic renal failure and dialysis; KTx = kidney transplantation; GFR = glomerular filtration rate; BMI = body mass index